Azafaros expands executive management team and operations

• Company attracts three experienced industry executives to lead preclinical and clinical development as well as finance and operations• Company incorporates Swiss subsidiary and gains additional investment from Schroder Adveq Leiden, The Netherlands, June 10th, 2020...

Confo Therapeutics Appoints Paolo Vicini as Chief Development Officer

--New management role underscores Company’s commitment to establishing and advancing its proprietary pipeline of GPCR modulating drug candidates-- Ghent, Belgium – June 3, 2020 - Confo Therapeutics today announced the appointment of Paolo Vicini, PhD, MBA, in the...

Confo Therapeutics reports grant of two key patents for ConfoBodies

Ghent, Belgium, 2 December 2019 – Confo Therapeutics, a pioneering biopharma company, today announces that it has been granted two key ConfoBodyTM patents derived from the patent estate known as the “Steyaert patents”. The Steyaert patents – named after Prof. Jan...